Aqdot
Aqdot (pronounced as “ay-queue-dot”) is a Cambridge (UK)-based supramolecular chemistry company with a focus and expertise in developing, licensing and selling novel proprietary products. Aqdot was spun out of the Chemistry Department in the University of Cambridge in 2013. Aqdot is making cucurbit[n]urils at multi-tonne scale for a variety of applications: areas from air filtering in transportation, odour/VOC capture in home/personal care and industrial environments; and in the biological area for allergen and virus inactivation and as a pharmaceutical delivery system for conventional therapeutics (e.g. for cancer) or nucleic acids (e.g. in vaccines). Aqdot has achieved REACH approval for the production of CB[n] at 100 tonne/annum.
Scientist in charge
Technology Leader
Andrew has 35+ years of experience in formulation and application of soft matter science. He has worked in R&D on product-process co-design at Schlumberger and Kodak and is now in his 6th year in understanding and applying Aqdot’s supramolecular chemistry. Andrew has published over 80 research papers (H-index 32) and 25 patents and served as an honorary visiting academic at the University of Cambridge’s BP Institute. Andrew has served his professional community: e.g. he is Immediate Past President of The British Society of Rheology, has served as chairman of the RSC/SCI UK Colloid Group and as President of the European Colloid and Interface Society ECIS.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 956150
©Storm-Bots. All rights reserved